HS-20093
Shanghai Hansoh Biomedical
['lung']
another adc targeting b7h3 showing activity in pts with small cell lung cancer! hs-20093's payload is a topo1 inhibitor (dar 4) and most frequent tox are hematological.
orr 63.6% in 11 pts, mpfs 4.7 months.
#asco23 
Medical Oncologist - Lung cancer & thymic tumors. Head of Clinical Research @GustaveRoussy - Head of Scientific Chairs Council @EORTC. Tweets are my own.